Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Long-COVID Syndrome | Research

Prevalence of covid-19 and long covid in collegiate student athletes from spring 2020 to fall 2021: a retrospective survey

Authors: Daisy Massey, Sharon Saydah, Blythe Adamson, Andrew Lincoln, Douglas F. Aukerman, Ethan M. Berke, Robby Sikka, Harlan M. Krumholz

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Symptomatic COVID-19 and Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 (PASC) or post-COVID conditions, have been widely reported in young, healthy people, but their prevalence has not yet been determined in student athletes. We sought to estimate the prevalence of reported COVID-19, symptomatic COVID-19, and Long COVID in college athletes in the United States attending 18 schools from spring 2020 to fall 2021.

Methods

We developed an online survey to measure the prevalence of student athletes who tested positive for COVID-19, developed Long COVID, and did not return to their sport during the relevant time period. We surveyed a convenience sample of 18 collegiate school administrators, representing about 7,000 student athletes. Of those schools surveyed, 16 responded regarding the spring 2020 semester, and 18 responded regarding the full academic year of fall 2020 to spring 2021 (both semesters).

Results

According to the survey responses, there were 9.8% of student athletes who tested positive for COVID-19 in spring 2020 and 25.4% who tested positive in the academic year of fall 2020 to spring 2021. About 4% of student athletes who tested positive from spring 2020 to spring 2021 developed Long COVID, defined as new, recurring, or ongoing physical or mental health consequences occurring 4 or more weeks after SARS-CoV-2 infection.

Conclusions

This study highlights that Long COVID occurs among young, healthy athletes and is a real consequence of COVID-19. Understanding the prevalence of Long COVID in this population requires longer follow-up and further study.
Footnotes
1
See e.g., 45 C.F.R. part 46. 102(I)(2), 21 C.F.R. part 56; 42 U.S.C. § 241 (d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq.
 
Literature
2.
go back to reference Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.CrossRefPubMed Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.CrossRefPubMed
3.
go back to reference Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626–31. Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626–31.
4.
go back to reference Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, Lambert N, Nurmi EL, Chakraborty R, Rahmani AM, Downs CA. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clin Nurs Res. 2022;31(8):1390–8. https://doi.org/10.1177/10547738221125632. Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, Lambert N, Nurmi EL, Chakraborty R, Rahmani AM, Downs CA. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clin Nurs Res. 2022;31(8):1390–8. https://​doi.​org/​10.​1177/​1054773822112563​2.
5.
go back to reference Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539–48. Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539–48.
7.
go back to reference Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.CrossRefPubMedPubMedCentral Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.CrossRefPubMedPubMedCentral
8.
go back to reference Wanga V, Chevinsky JR, Dimitrov LV, et al. Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235–41.CrossRefPubMedPubMedCentral Wanga V, Chevinsky JR, Dimitrov LV, et al. Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235–41.CrossRefPubMedPubMedCentral
10.
go back to reference Schultz EA, Kussman A, Jerome A, Abrams GD, Hwang CE. Comparison of SARS-CoV-2 test positivity in NCAA division I student athletes vs nonathletes at 12 institutions. JAMA Netw Open. 2022;5(2):e2147805–e2147805.CrossRefPubMedPubMedCentral Schultz EA, Kussman A, Jerome A, Abrams GD, Hwang CE. Comparison of SARS-CoV-2 test positivity in NCAA division I student athletes vs nonathletes at 12 institutions. JAMA Netw Open. 2022;5(2):e2147805–e2147805.CrossRefPubMedPubMedCentral
11.
go back to reference Rao P, Peritz DC, Systrom D, Lewine K, Cornwell WK 3rd, Hsu JJ. Orthostatic and exercise intolerance in recreational and competitive athletes with long COVID. JACC Case Rep. 2022;4(17):1119–23.CrossRefPubMedPubMedCentral Rao P, Peritz DC, Systrom D, Lewine K, Cornwell WK 3rd, Hsu JJ. Orthostatic and exercise intolerance in recreational and competitive athletes with long COVID. JACC Case Rep. 2022;4(17):1119–23.CrossRefPubMedPubMedCentral
12.
go back to reference Schwendinger F, Knaier R, Radtke T, Schmidt-Trucksäss A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53(1):51–74.CrossRefPubMed Schwendinger F, Knaier R, Radtke T, Schmidt-Trucksäss A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53(1):51–74.CrossRefPubMed
14.
go back to reference Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568–e2128568.CrossRefPubMedPubMedCentral Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568–e2128568.CrossRefPubMedPubMedCentral
15.
go back to reference Casasco M, Iellamo F, Scorcu M, et al. Return to play after SARS-CoV-2 infection in competitive athletes of distinct sport disciplines in Italy: a FMSI (Italian Federation of Sports Medicine) study. J Cardiovasc Dev Dis. 2022;9(2):59. Casasco M, Iellamo F, Scorcu M, et al. Return to play after SARS-CoV-2 infection in competitive athletes of distinct sport disciplines in Italy: a FMSI (Italian Federation of Sports Medicine) study. J Cardiovasc Dev Dis. 2022;9(2):59.
16.
go back to reference Guevarra CC, Murray N, Cipriani D, et al. Cardiovascular involvement among collegiate athletes following COVID-19 infection. J Clin Transl Res. 2022;8(1):1–5.PubMedPubMedCentral Guevarra CC, Murray N, Cipriani D, et al. Cardiovascular involvement among collegiate athletes following COVID-19 infection. J Clin Transl Res. 2022;8(1):1–5.PubMedPubMedCentral
17.
go back to reference Lakatos BK, Tokodi M, Fábián A, et al. Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: a propensity score-matched analysis. Front Cardiovasc Med. 2021;8:760651.CrossRefPubMed Lakatos BK, Tokodi M, Fábián A, et al. Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: a propensity score-matched analysis. Front Cardiovasc Med. 2021;8:760651.CrossRefPubMed
18.
go back to reference Radin JM, Quer G, Ramos E, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open. 2021;4(7):e2115959.CrossRefPubMedPubMedCentral Radin JM, Quer G, Ramos E, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open. 2021;4(7):e2115959.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of covid-19 and long covid in collegiate student athletes from spring 2020 to fall 2021: a retrospective survey
Authors
Daisy Massey
Sharon Saydah
Blythe Adamson
Andrew Lincoln
Douglas F. Aukerman
Ethan M. Berke
Robby Sikka
Harlan M. Krumholz
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08801-z

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine